Levamisole+cyclosporin A+Glucocorticoids ( DrugBank: Cyclosporin, Cyclosporin A, Levamisole )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
60	再生不良性貧血	2
62	発作性夜間ヘモグロビン尿症	2

60. 再生不良性貧血

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01760096 (ClinicalTrials.gov)	January 2013	1/1/2013	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysm ...	Phase II Study of the Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysma ...	Paroxysmal Nocturnal Hemoglobinuria;Hemoglobinuria;Hemoglobinuria, Paroxysmal;Proteinuria;Urination ...	Drug: Levamisole+cyclosporin A+Glucocorticoids;Drug: cyclosporin A+Glucocorticoids;Drug: Glucocortic ...	Institute of Hematology & Blood Diseases Hospital	NULL	Active, not recruiting	18 Years	N/A	Both	50	Phase 2	China
2	NCT01642979 (ClinicalTrials.gov)	July 2012	14/7/2012	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal N ...	Phase II Study of the Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal No ...	Paroxysmal Nocturnal Hemoglobinuria;Hemoglobinuria;Hemoglobinuria, Paroxysmal;Proteinuria;Urination ...	Drug: Levamisole+cyclosporin A+Glucocorticoids;Drug: cyclosporin A+Glucocorticoids;Drug: Glucocortic ...	Institute of Hematology & Blood Diseases Hospital	NULL	Active, not recruiting	18 Years	N/A	Both	120	Phase 2	China

臨床試験数 : 292 / 薬物数 : 151 - (DrugBank : 49) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 108

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01760096 (ClinicalTrials.gov)	January 2013	1/1/2013	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysm ...	Phase II Study of the Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysma ...	Paroxysmal Nocturnal Hemoglobinuria;Hemoglobinuria;Hemoglobinuria, Paroxysmal;Proteinuria;Urination ...	Drug: Levamisole+cyclosporin A+Glucocorticoids;Drug: cyclosporin A+Glucocorticoids;Drug: Glucocortic ...	Institute of Hematology & Blood Diseases Hospital	NULL	Active, not recruiting	18 Years	N/A	Both	50	Phase 2	China
2	NCT01642979 (ClinicalTrials.gov)	July 2012	14/7/2012	Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal N ...	Phase II Study of the Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal No ...	Paroxysmal Nocturnal Hemoglobinuria;Hemoglobinuria;Hemoglobinuria, Paroxysmal;Proteinuria;Urination ...	Drug: Levamisole+cyclosporin A+Glucocorticoids;Drug: cyclosporin A+Glucocorticoids;Drug: Glucocortic ...	Institute of Hematology & Blood Diseases Hospital	NULL	Active, not recruiting	18 Years	N/A	Both	120	Phase 2	China